fluorouracil (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the fluorouracil drug offered from Sagent Pharmaceuticals. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | fluorouracil |
| SUBSTANCE NAME: | FLUOROURACIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-15 |
| END MARKETING DATE: | 0000-00-00 |
fluorouracil HUMAN PRESCRIPTION DRUG Details:
| Item Description | fluorouracil from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2016-09-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-215_2fcef624-1d6a-43ad-873b-495048cfc763 |
| PRODUCT NDC: | 25021-215 |
| APPLICATION NUMBER: | ANDA203609 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers:
